Aurinia Pharmaceuticals Inc. (AUPH) Ownership

$11.35

north_east
$0.09 (0.8%)
Day's range
$11.18
Day's range
$11.4

Aurinia Pharmaceuticals Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
TANG CAPITAL MANAGEMENT LLC 11/14/2025 11.33 M $125.19 M   12.96% 8.16%
BLACKROCK, INC. 11/12/2025 7.45 M $82.31 M   -3.18% 5.36%
NEA MANAGEMENT COMPANY, LLC 11/14/2025 3.97 M $43.87 M   0.00% 2.86%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 11/13/2025 3.37 M $37.28 M   213.54% 2.43%
STATE STREET CORP 11/14/2025 2.69 M $29.77 M   -3.63% 1.94%
MORGAN STANLEY 11/14/2025 1.95 M $21.51 M   -18.76% 1.40%
VANGUARD GROUP INC 11/07/2025 1.56 M $17.21 M   -9.49% 1.12%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 1.49 M $16.41 M   -5.79% 1.07%
MARSHALL WACE, LLP 11/13/2025 1.48 M $16.39 M   1,272.51% 1.07%
RENAISSANCE TECHNOLOGIES LLC 11/13/2025 1.45 M $16.02 M   25.20% 1.04%
TWO SIGMA INVESTMENTS, LP 11/14/2025 1.34 M $14.82 M   728.60% 0.97%
JACOBS LEVY EQUITY MANAGEMENT, INC 11/17/2025 1.22 M $13.47 M   63.00% 0.88%
QUBE RESEARCH & TECHNOLOGIES LTD 11/14/2025 1.15 M $12.74 M   -7.22% 0.83%
JANUS HENDERSON GROUP PLC 11/14/2025 1.04 M $11.50 M   369.96% 0.75%
D. E. SHAW & CO., INC. 11/14/2025 909.92 K $10.05 M   166.42% 0.66%
NORTHERN TRUST CORP 11/14/2025 896.45 K $9.91 M   -2.69% 0.65%
GOLDMAN SACHS GROUP INC 11/14/2025 842.03 K $9.30 M   91.80% 0.61%
JUPITER ASSET MANAGEMENT LTD 11/10/2025 823.58 K $9.10 M   -11.81% 0.59%
TREXQUANT INVESTMENT LP 11/14/2025 801.08 K $8.85 M   100.56% 0.58%
CITADEL ADVISORS LLC 11/14/2025 702.66 K $7.76 M   497.31% 0.51%
JANE STREET GROUP, LLC 11/14/2025 677.25 K $7.48 M   45.14% 0.49%
DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN 11/14/2025 565.96 K $6.25 M   0.00% 0.41%
SQUAREPOINT OPS LLC 11/14/2025 555.70 K $6.14 M   14.83% 0.40%
RICE HALL JAMES & ASSOCIATES, LLC 10/16/2025 542.56 K $6.00 M   -1.44% 0.39%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 11/13/2025 541.19 K $5.98 M   -16.76% 0.39%
JPMORGAN CHASE & CO 11/26/2025 533.29 K $5.89 M   21.66% 0.38%
BANK OF AMERICA CORP /DE/ 11/14/2025 521.36 K $5.76 M   10.74% 0.38%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 11/14/2025 512.57 K $5.66 M   100.00% 0.37%
JUMP FINANCIAL, LLC 11/13/2025 496.31 K $5.48 M   27.23% 0.36%
TWO SIGMA ADVISERS, LP 11/14/2025 479.90 K $5.30 M   169.61% 0.35%
WOODLINE PARTNERS LP 11/14/2025 456.26 K $5.04 M   -8.82% 0.33%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 437.95 K $4.84 M   -14.42% 0.32%
BNP PARIBAS ARBITRAGE, SNC 11/13/2025 421.36 K $4.66 M   3,132.76% 0.30%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 409.40 K $4.52 M   1.09% 0.29%
JANE STREET GROUP, LLC 11/14/2025 393.00 K $4.34 M   28.77% 0.28%
NORDEA INVESTMENT MANAGEMENT AB 10/27/2025 359.10 K $4.03 M   1.15% 0.26%
AQR CAPITAL MANAGEMENT LLC 11/14/2025 358.29 K $3.96 M   66.92% 0.26%
LAZARD ASSET MANAGEMENT LLC 11/14/2025 355.67 K $3.93 M   -55.47% 0.26%
LPL FINANCIAL LLC 11/12/2025 323.31 K $3.57 M   429.91% 0.23%
NOMURA HOLDINGS INC 11/14/2025 316.19 K $3.49 M   1,423.83% 0.23%
BANK OF NEW YORK MELLON CORP 11/03/2025 313.50 K $3.46 M   -3.78% 0.23%
AMERICAN CENTURY COMPANIES INC 11/12/2025 307.44 K $3.40 M   14.05% 0.22%
NUVEEN, LLC 11/12/2025 305.23 K $3.37 M   14.77% 0.22%
STATE OF WISCONSIN INVESTMENT BOARD 11/14/2025 283.10 K $3.13 M   7.92% 0.20%
ROYAL BANK OF CANADA 11/14/2025 276.32 K $3.05 M   -1.50% 0.20%
HOOD RIVER CAPITAL MANAGEMENT LLC 11/14/2025 269.31 K $2.98 M   100.00% 0.19%
PDT PARTNERS, LLC 11/17/2025 265.49 K $2.93 M   -19.23% 0.19%
IFP ADVISORS, INC 12/02/2025 262.38 K $2.91 M   0.90% 0.19%
RAYMOND JAMES FINANCIAL INC 11/14/2025 236.12 K $2.61 M   -0.41% 0.17%
SWISS NATIONAL BANK 11/13/2025 222.90 K $2.46 M   0.00% 0.16%

Aurinia Pharmaceuticals Inc. institutional Ownership - FAQ's

During the previous two years, 303 institutional investors and hedge funds held shares of Aurinia Pharmaceuticals Inc.. The most heavily invested institutionals were:

TANG CAPITAL MANAGEMENT LLC: 11.33 M

BlackRock, Inc.: 7.45 M

NEA Management Company, LLC: 3.97 M

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP: 3.37 M

STATE STREET CORP: 2.69 M

MORGAN STANLEY: 1.95 M

47.28% of Aurinia Pharmaceuticals Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 80.89 M shares in the last 24 months. This purchase volume represents approximately $918.08 M in transactions.